Panhematin Market Analysis, Share, Industry & Revenue [2030]

Segments - Panhematin Market by Types (350mg and 313mg), Applications (Hospitals and Pharmacies), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

The global panhematin market size is projected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is rising incidence of blood disorders across the globe.

Panhematin is a germ-free lyophilized powder, which is appropriate for intravenous administration. It is given by injection into the vein as directed by physician. The dosage is based on weight, medical conditions, and response to therapy. Panhematin provide therapeutic benefits in treating patients with pancreatitis.

Panhematin is use for intravenous infusion only. The standard dose of panhematin in clinical practice is three to four mg/kg/day. Repeated dose is given in more severe cases, which is no earlier than every 12 hours. The dose may be administered directly from the vial over a period of at least 30 minutes. After the injection, vein is flushed by using 100 mL of 0.9% NaCl.

Market Trends, Drivers, Restraints, and Opportunities

Increasing demand in various regions around the globe due to the rising cases of porphyria related to the menstrual cycle in women is projected to drive the market demand in the projected timeline
Growing health concerns is anticipated to propel the market expansion during the forecast period.
The COVID-19 pandemic has increased the burden on the healthcare sector, positively influencing the market growth.
Side effects such as swelling, rapid weight gain, and shortness in breathing can hinder the market growth during the forecast period.
Panhematin cannot be stored at home as it is usually given in hospitals or clinics, restricting the market expansion during the forecast period.
Rising R&D investment is projected to create lucrative opportunities for the market growth during the forecast period.

Scope of Panhematin Market Report

The report on the global panhematin market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Panhematin Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2020
Historic Data	2018–2019
Forecast Period	2021–2028
Segmentation	Types (350mg and 313mg), Applications (Hospitals and Pharmacies)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Abbot

Panhematin Market Segment Insights

313 mg segment is projected to account for a large market share

On the basis of types, the panhematin market is bifurcated into 350 mg and 313 mg. The 313 mg segment is expected to account for a major market share during the forecast period. The product contains no preservatives. When panhematin is mixed as directed with sterile water for injection, each 43 ml provides the equivalent of approximately 301 mg hematin.

Each dispensing vial of panhematin contains the equivalent of 313 mg hemin, 215 mg sodium carbonate, and 300 mg of sorbitol. The pH can be adjusted with hydrochloric acid. The dosage is based on your weight, medical conditions, and response to therapy.

Hospitals segment is anticipated to register a substantial CAGR

In terms of applications, the panhematin market is classified as hospitals and pharmacies.

The hospitals segment is anticipated to expand at a substantial CAGR during the forecast period. Monitoring of the patient is required after administration of panhematin injection. It is given by injection into a vein by professional practitioner in hospitals. Before using panhematin, one need to consult doctor related to allergies as this product may consist of inactive ingredients, which can cause allergic reactions or other problems.

North America is anticipated to dominate the market

On the basis of regions, the panhematin market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market during the forecast period. The regional market growth is attributed to adoption of latest technology for manufacturing of panhematin medicine. Moreover, the presence of major industry players in the countries such as the US and Canada is expected to proliferate the growth of the market in the region.

The market in Asia Pacific is anticipated to exhibit a high CAGR during the forecast period. Increasing incidence of blood-related disorders is driving the growth of the market in the region. Rising number of hospitals owing to increasing investment in the healthcare infrastructure is propelling the regional market growth.

Segments

The global panhematin market has been segmented on the basis of

Types

350mg
313mg

Applications

Hospitals
Pharmacies

Regions

Asia Pacific
North America
Latin America
Europe
Middle East & Africa

Key Players

Abbot

Competitive Landscape

Key players competing in the panhematin market include Abbot.

Global Panhematin Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Panhematin Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Panhematin Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Panhematin Market - Supply Chain
  4.5. Global Panhematin Market Forecast
     4.5.1. Panhematin Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Panhematin Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Panhematin Market Absolute $ Opportunity
5. Global Panhematin Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Panhematin Market Size and Volume Forecast by Types
     5.3.1. 350mg 313mg
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Panhematin Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. Panhematin Market Size and Volume Forecast by Applications
     6.3.1. Hospitals Pharmacies
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Panhematin Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Panhematin Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Panhematin Demand Share Forecast, 2019-2026
8. North America Panhematin Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Panhematin Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Panhematin Market Size and Volume Forecast by Types
     8.4.1. 350mg 313mg
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Panhematin Market Size and Volume Forecast by Applications
     8.7.1. Hospitals Pharmacies
  8.8. Basis Point Share (BPS) Analysis by Applications
  8.9. Y-o-Y Growth Projections by Applications
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Panhematin Demand Share Forecast, 2019-2026
9. Latin America Panhematin Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Panhematin Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Panhematin Market Size and Volume Forecast by Types
     9.4.1. 350mg 313mg
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Panhematin Market Size and Volume Forecast by Applications
     9.7.1. Hospitals Pharmacies
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Panhematin Demand Share Forecast, 2019-2026
10. Europe Panhematin Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Panhematin Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Panhematin Market Size and Volume Forecast by Types
     10.4.1. 350mg 313mg
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Panhematin Market Size and Volume Forecast by Applications
     10.7.1. Hospitals Pharmacies
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Panhematin Demand Share Forecast, 2019-2026
11. Asia Pacific Panhematin Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Panhematin Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Panhematin Market Size and Volume Forecast by Types
     11.4.1. 350mg 313mg
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Panhematin Market Size and Volume Forecast by Applications
     11.7.1. Hospitals Pharmacies
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Panhematin Demand Share Forecast, 2019-2026
12. Middle East & Africa Panhematin Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Panhematin Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Panhematin Market Size and Volume Forecast by Types
     12.4.1. 350mg 313mg
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Panhematin Market Size and Volume Forecast by Applications
     12.7.1. Hospitals Pharmacies
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Panhematin Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Panhematin Market: Market Share Analysis
  13.2. Panhematin Distributors and Customers
  13.3. Panhematin Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Abbot